Introduction
Retroviruses have been linked to leukaemia in many animal species, and the search for a human retrovirus was first accomplished with the discovery of a type C retrovirus of truly human origin by Gallo and coworkers, which was quite distinct from any known animal retrovirus. This agent, the human T cell leukaemia/lymphoma virus type I (HTLV-I), was initially isolated from two black adults said to have mycosis fungoides and the Sezary syndrome' I but who in retrospect had adult T cell leukaemia/lymphoma.
The link of HTLV-I to this clinical entity was made in serological studies of Japanese patients with adult T cell leukaemia/lymphoma, by the recognition that HTLV-I associated patients in the United States had this syndrome, and by the observation of the clinical syndrome in six black patients in London who originated from the West Indian islands St Vincent, Grenada, and Trinidad and from Guyana,3 all of whom were shown to be positive for HTLV-I antibodies. 4 Before this, no such cases had been reported in West Indians living in the West Indies.
Subsequently the detection of antibody positive carriers in the region supported the concept that the West Indies are an HTLV-I endemic region. 5 Further support for this concept has come from studies in Jamaica,6 where 11 (69%) of 16 consecutive patients with non-Hodgkin's lymphoma newly diagnosed between 1 February 1982 and 31 January 1983 had antibodies to HTLV-I in their sera.
A retroviral aetiology for the acquired immune deficiency syndrome (AIDS) was suggested initially by the finding of antibodies to HTLV-I in a high proportion of patients with AIDS, using an HTLV-I membrane antigen assay.7 AIDS is, however, rare or absent in most areas where HTLV-I is endemic. This discrepancy has been clarified by the recent discovery of a distinct but distantly cross reactive class of human retroviruses, HTLV-III, which has similar cellular trophism to HTLV-I but with a pronounced cytopathic effect. 8 Here we summarise the features of the distribution of both these agents in an island (Trinidad) where HTLV-I is suspected to be endemic and their relations to adult T cell leukaemia/ lymphoma and AIDS. The first case of adult T cell leukaemia/ lymphoma was diagnosed in May 1982 and that of AIDS in February 1983. This case series represents all such patients seen up to June 1984.
Patients and methods
Adult T cell leukaemia/lymphoma-The morphology of the lymphoid cells in the peripheral blood and bone marrow was examined by light microscopy on films stained with the Wright-Giemsa stain. Calcium concentrations were determined using autoanalyser methods. Carboxyterminal parathyroid hormone assays were performed. The presence of T lymphocytes in the peripheral blood was determined in three patients by rosette formation with red cells from sheep after cytocentrifuged preparations had been stained with brilliant cresyl blue. Sera were collected under sterile conditions and stored at -70°C until assayed for HTLV-I antibodies.
AIDS-Patients with AIDS were selected by the diagnostic criteria proposed for defining AIDS by the Centre for Disease Control. Sera were collected under sterile conditions and stored at -70°C until assayed for HTLV-III antibodies.
HTLV antibody assays-All sera were tested for HTLV antibodies by an indirect enzyme linked immunosorbent assay (ELISA) as previously described,9 using disrupted whole purified virus as the antigen. Antibodies to HTLV-I were confirmed by blocking with virus specific heteroantisera. 10 Calcium studies-Seven patients (58%) had hypercalcaemia. One (case 4) presented with bone pain and was found to have widespread osteolytic bone lesions; he died in hypercalcaemic coma. In another patient (case 6) parathyroid hormone assay was 973 pg/ml (normal range 150-450 pg/ml) but no bone lesions were seen. On the other hand, in a third patient (case 7) one osteolytic lesion was found in his skull but the only test for serum calcium concentration done was normal.
Skin lesions-The affinity that the malignant cells of cutaneous T cell lymphomas display for the skin becomes apparent as clinically evident cutaneous infiltrations, present in eight patients (67%). All the biopsies of the skin were diagnostic of lymphoma. Most of these eight patients (table I) had generalised nodular lesions. One patient (case 11) had maculopapular lesions restricted to the palms and soles. Another (case 8) had a diffuse erythroderma. In a third (case 3) the skin lesions presented two years before the appearance of enlarged lymph nodes and a clinically aggressive course.
Immunological cell marker studies-In three patients (cases 5, 10, and 11) E rosette studies were done and the E rosette positive cells represented 92%, 80%, and 9233%, respectively, of the lymphoid cells.
HTLV-I antibody studies-All the sera from the patients contained antibody to HTLV-I, with titres ranging from 20 to 140 000. Table II gives details of the patients with AIDS. All were homosexual men of African descent. The opportunistic infections of these patients were due to Cryptococcus neoformans, Toxoplasma gondii, Candida albicans, histoplasmosis, tuberculosis, Herpes simplex, and Pneumocystis carinii. There was only one patient with Kaposi's sarcoma, and one patient had a Burkitt's like lymphoma.
AIDS
HTL V-III antibody studies-The sera of 11 patients were positive for antibodies to HTLV-III, with titres ranging from 8694 to 791 108. The sera of three patients who died were unavailable for study. Conversion: SI to traditional units-Calcium: 1 mmol/l z 4 mg/ 100 ml. *Normal range 21-5-26-5 mmol/l. Discussion Adult T cell leukaemia was first recognised as a new clinicopathological entity of T cell malignancy by Takatsuki et al."3 A striking feature of the disease was that it was restricted to the Kyushu and Shikoku districts in southwest Japan. This geographical localisation suggested that some unique factors were involved in adult T cell leukaemia, and an infectious aetiology was postulated. The link, however, to a retroviral aetiology emerged only with the discovery of HTLV-I by Poiesz et al.' 2 A unifying hypothesis linking exposure to this virus to this particular disease has emerged from the recognition of geographical clusters of cases of adult T cell leukaemia/lymphoma not only in Japan but also in blacks from the southern United States and the West Indies. In addition, sporadic cases from widely dispersed geographical areas have been recognised by their characteristic clinicopathological features and the presence of retroviral antibodies.14 A study in Jamaica showed that, of 16 consecutive patients presenting with non-Hodgkin's lymphoma, 11 (69'%) had antibodies to HTLV-I in their sera and that these 11 patients shared features with those documented in this report from Trinidad as well as those reported from Japan.6 Thus the West Indies is clearly another area, in addition to southwest Japan, where adult T cell leukaemia/lymphoma is endemic. More recently, nine (200o) of 44 patients with lymphoproliferative diseases in the French West Indies (Martinique) were found to be positive for HTLV-I antibodies. '5 In the United Kingdom the HTLV-I disease association has to date been restricted to first generation immigrants from the West Indies.' Several of these patients had lived in the United Kingdom for as long as 20 years, suggesting a long latent period between infection and overt lymphoma/leukaemia.
Antibodies against HTLV-I have also been found in six (3-7°) of 161 blood donors'6 and in two patients with lymphoproliferative disease in Nigeria.'7 Although suggestive, it is as yet too early to conclude that Nigeria represents another cluster area for HTLV-I associated disease. In all these locales where clusters of adult T cell leukaemia/lymphoma have been found high titres of background infection in the normal population have been detected and persistent infection for over 10 In the original study of West Indian immigrants in the United Kingdom four of the six patients were women,3 and in the Jamaican study 12 of the 19 patients with lymphoproliferative malignancies and positive for HTLV-I antibodies were women.6 This led Blattner et al to comment that in the study in the United Kingdom selective migration patterns would have contributed to the excess of women and that the Jamaican series suggested a true preponderance of women, reflecting either an underlying disproportionate population prevalence of HTLV infection among women or an unexplained susceptibility of women to the disease.6 On the other hand, our report has shown a distinct male excess (eight men to four women). As these series comprised relatively small numbers of patients larger numbers of patients should help to clarify this pattern.
One of the striking features of adult T cell leukaemia/lymphoma is the tendency of cases to be clustered geographically. This has certainly been noticeable in Japan and may be found in the West Indies as well. There is, however, a tendency for the West Indian islands, strewn as they are over 1700 km, to be considered to have identical disease patterns. As is well recognised with respect to other living conditions, however, the geographical distribution of many diseases is not uniform in these islands so that studies of the prevalence of HTLV antibodies in different locales in the region need to be undertaken. For example, it is interesting that no clinical cases of adult T cell leukaemia/lymphoma have been recognised so far in Barbadians living in Barbados.
None the less the overall data suggest that adult T cell leukaemia/lymphoma is widely distributed in the West Indies with a predilection for affecting blacks. Gallo United Kingdom take a benzodiazepine as an anxiolytic or hypnotic. ' In 1977 diazepam was the drug most commonly prescribed by general practitioners, accounting for 4-3°O of all prescriptions.' These figures reflect the tendency for most anxiety disorders to be treated in primary care, less than 10%, being referred to psychiatrists.3 Few studies assessing the efficacy of benzodiazepines, however, are carried out in a primary care setting; most are carried out with psychiatric outpatients.4
Despite the widespread use of benzodiazepines persistent criticisms have been raised about the lack of efficacy after prolonged use,5-' "rebound" anxiety,8 and the emergence of withdrawal symptoms at the end of treatment.9-" Studies of the withdrawal of benzodiazepine after the administration of recommended short term therapeutic doses have been few.6" In many cases high doses of benzodiazepines have been used13-"5 or patients have been maintained within recommended doses for prolonged periods (one to 16 years) before withdrawal of the drug. [16] [17] [18] Our study compared the effectiveness of diazepam versus placebo in the management of generalised anxiety over a six week double blind period in a primary care setting. Withdrawal reactions from diazepam were investigated during a two week withdrawal period, when single blind placebo was substituted for the double blind active treatment. The effect of placebo on the state of anxiety at initial presentation was assessed during one week's single blind treatment with placebo before the double blind treatment was started.
Patients and methods
Patients were initially screened for psychological and physical morbidity by their general practitioner and were told the nature of the
